Uncommon side‐effects of interferon

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of Viral Hepatitis

• Publication date

  1997-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2893.1997.tb00167.xPMID 9097285
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Renal allograft function in patients with chronic viral hepatitis B and C treated with interferon alpha.

  1995cited by this paper
• Retinopathy and subconjunctival haemorrhage in patients with chronic viral hepatitis receiving interferon alfa.

  1995cited by this paper
• Reversible diabetes in patient with AIDS-related Kaposi's sarcoma treated with interferon α-2a

  1995cited by this paper
• Reversible diabetes in patient with AIDS-related Kaposi's sarcoma treated with interferon alpha-2a.

  1995cited by this paper
• Clinical Toxicity of the Interferons

  1994cited by this paper
• Suicide associated with alfa-interferon therapy for chronic viral hepatitis.

  1994cited by this paper
• Optic tract neuropathy complicating low-dose interferon treatment.

  1994cited by this paper
• Sudden hearing loss associated with interferon.

  1994cited by this paper
• Pneumonitis associated with natural and recombinant interferon alfa therapy for chronic hepatitis C.

  1994cited by this paper
• Acute renal failure during interferon treatment.

  1993cited by this paper
• Acute renal failure with α-interferon therapy: a case report

  1993cited by this paper
• Interferon-associated retinopathy.

  1993cited by this paper
• Telogen effluvium due to recombinant interferon alpha-2b.

  1992cited by this paper
• Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis.

  1992cited by this paper
• Telogen Effluvium due to Recombinant Interferon α-2b

  1992cited by this paper
• Cardiotoxicity of interferon. A review of 44 cases.

  1991cited by this paper
• Seizures associated with low-dose alpha-interferon.

  1990cited by this paper
• Treatment of chronic hepatitis C with recombinant α-interferon. A multicentre randomized, controlled trial

  1990cited by this paper
• Treatment of chronic hepatitis C with recombinant alpha-interferon. A multicentre randomized, controlled trial. The Hepatitis Interventional Therapy Group.

  1990cited by this paper
• Seizures associated with low-dose α-interferon

  1990cited by this paper
• Effect of Interferon on Glucose Tolerance and Insulin Sensitivity

  1989cited by this paper
• Clinical toxicity of interferons in cancer patients: a review.

  1986cited by this paper
• Neurological effects of recombinant human interferon.

  1983cited by this paper

• Use of immunostimulants in the successful treatment of a clinical EEHV1A infection in an Asian elephant (Elephas maximus)

  2020cites this paper
• Effect of competition bias in safety signal generation: analysis of a research database of spontaneous reports in France.

  2012cites this paper
• Effect of Competition Bias in Safety Signal Generation

  2012cites this paper
• SYT‐SSX breakpoint peptide vaccines in patients with synovial sarcoma: A study from the Japanese Musculoskeletal Oncology Group

  2012cites this paper
• Side effects of interferon-alpha therapy.

  2005cites this paper
• Side Effects of Interferon-α Therapy

  2005cites this paper
• Comprehensive Review of Hepatitis C for Psychiatrists: Risks, Screening, Diagnosis, Treatment, and Interferon-Based Therapy Complications

  2003cites this paper
• Minimal Change Disease in a Patient Receiving IFN-α Therapy for Chronic Hepatitis C Virus Infection

  2003cites this paper
• Drugs acting on the immune system

  2003cites this paper
• Reversible posterior leukoencephalopathy syndrome in hepatitis C virus-positive long-term hemodialysis patients.

  2001cites this paper
• Intracerebral haemorrhage under interferon‐β therapy

  2001cites this paper
• Oropharyngeal pemphigus in a patient with chronic hepatitis C during interferon alpha-2a therapy.

  2001cites this paper
• Oropharyngeal pemphigus in a patient with chronic hepatitis C during interferon alpha-2a therapy

  2001cites this paper
• Transitory ischemic attack and acute hepatitis C.

  2000cites this paper
• [Multiple cerebral infarcts associated with livedo secondary to anti-cancer therapy with interleukin 2 and interferon alpha].

  2000cites this paper
• Transitory ischemic attack and acute hepatitis C

  2000cites this paper
• Hepatitis C virus infection: Review and implications for the dentist.

  1998cites this paper
• Pharmacokinetics of alphaIFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: clinical implications.

  1998cites this paper
• [Viral hepatitis C and G (Hepacivirus, Flaviviridae): etiotropic therapy].

  1998cites this paper